Boston Celtics reportedly signing Kristaps Porzingis to two-year extension


The Boston Celtics are reportedly signing star big man Kristaps Porzingis to a deal rumored to be a two-year, $60 million extension after having traded away veteran point guard Marcus Smart to the Memphis Grizzlies in order to land the Latvian center in a three-team deal also including the Washington Wizards earlier in the week.

This move provides a modicum of long-term security for Porzingis and solidifies the Celtics’ core of key players for the next three seasons. The contract is considered a good deal for both parties, with the Celtics getting a versatile player at a reasonable price, and Porzingis having the opportunity to showcase his skills in a competitive market.

To hear more about the extension and its potential impact for all parties, check out the clip embedded below that features the hosts of the NBC Sports Boston’s 2023 Free Agency Special to learn more.

Listen to the “Celtics Lab” podcast on:

Apple Podcasts: https://apple.co/3zBKQY6

Spotify: https://spoti.fi/3GfUPFi

YouTube:

More Analysis!

Could a Grant Williams return to the Boston Celtics be market-dependant?

Story originally appeared on Celtics Wire



Source link: https://sports.yahoo.com/boston-celtics-reportedly-signing-kristaps-180326235.html?src=rss

Sponsors

spot_img

Latest

Canan Moodie hat-trick stands out in Bulls’ rampage versus Zebre

The Bulls closed in on the URC playoffs with a 78-12 thrashing of Zebre Parma in Johannesburg. Wing Canan Moodie claimed a...

Startup founders: Don’t cross the line between optimism and fraud

Check out all the on-demand sessions from the Intelligent Security Summit here. In early September, former Theranos CEO Elizabeth Holmes requested a new trial,...

Ethereum Merge Is One: Here Are The Highlights So Far

It has been a year since the Merge took place, and as expected, the world’s second largest cryptocurrency, Ethereum, has experienced many changes...

FDA Will No Longer Require Animal Tests Before Human Trials for All Drugs

Animal testing will no longer be a mandated part of the Food and Drug Administration’s approval process for all new drugs. Since 1938,...